Long-Term Safety and Efficacy Study of Peginterferon Beta-1a

Completed · Phase 3

Conditions studied: Relapsing Multiple Sclerosis

In brief

The primary objective of this study is to evaluate the long-term safety and tolerability of peginterferon beta-1a (BIIB017) in participants originally treated in Study 105MS301 (NCT00906399) who continue peginterferon beta-1a treatment. The secondary objective of this study is to describe long-term multiple sclerosis (MS) outcomes in participants originally treated in Study 105MS301 (NCT00906399) who continue peginterferon beta-1a treatment.

Key facts

Study ID
NCT01332019
Run by
Biogen
People needed
1077
Starts
2011-04-01
Expected to finish
2015-10-01
Last updated by the study team
2017-01-13

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.